Miglitol is an oral anti-diabetic drug. Miglitol, and other structurally-related iminosugars, inhibit glycoside hydrolase enzymes called alpha-glucosidases, thereby inhibiting the ability of a patient to break down complex carbohydrates into glucose. Miglitol is systemically absorbed, but is not metabolized and is excreted by the kidneys.

Grade: IP / BP